Delivery Order HSHQDC10D00025-HSHQDC13J00078

The Defense Logistics Agency Troop Support Medical awarded a $24,438.75 firm fixed price delivery order contract to Glaxosmithkline, LLC for the provision of zanamivir for inhalation. Glaxosmithkline will deliver the contracted pharmaceutical products to a location in Durham, North Carolina by March 18, 2024 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The contract utilizes the Defense...

The Defense Logistics Agency Troop Support Medical awarded a $30,438 delivery order to Amerisourcebergen Drug Corporation for the supply of 100mg Renflexis vials. The firm fixed price order is for performance from September 8 to October 5, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. Renflexis is a biosimilar to infliximab used to treat various autoimmune disorders. This small order was issued under an existing DLA pharmaceutical supply vehicle and does not have any set...

This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $3,928.00 and a completion date of September 27, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...

This federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of REXULTI 2 MG TABLET 30S medical supplies. The fixed-price delivery order, valued at $6,807.19, has a completion date of November 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...

Glaxosmithkline, LLC was awarded a $5,250 firm fixed price delivery order against an unidentified contracting vehicle to provide 8509429652, zanamivir for inhalation, to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 17, 2023 and was awarded on September 27, 2022 without a set-aside designation. Glaxosmithkline will deliver the requested pharmaceutical products to the agency's location in Research Triangle Park, North Carolina...

The Defense Logistics Agency awarded a $2,693.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of Renflexis, a biosimilar treatment for rheumatoid arthritis. The single day order is to be fulfilled on July 11th through the 12th, with performance taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The Defense Logistics Agency routinely issues such orders under existing...

The Defense Logistics Agency Troop Support Medical awarded a $2,252 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561851792 Renflexis 100 mg vials. The place of performance is Conshohocken, Pennsylvania. The period of performance is from August 17, 2023 through August 18, 2023. This delivery order was issued against an existing DLA medical supply vehicle to provide the specified pharmaceutical product in support of DOD health care programs. No subcontractors or set...

Glaxosmithkline, LLC was awarded a $52,500 firm fixed price delivery order against an unidentified contract vehicle to supply zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 2023 and was awarded on September 27, 2022 without a set-aside designation. Glaxosmithkline will provide the pharmaceutical products from its location in Research Triangle Park, North Carolina to support the Defense Logistics...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REXULTI 0.5 MG TABLET 30S. The order has a completion date of March 8, 2024 and a potential value of $4,592.77. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...

Glaxosmithkline, LLC was awarded a $176,400 firm fixed price delivery order against an unidentified contract vehicle to provide Zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 2023 and was awarded on September 27, 2022 without a set-aside designation. Glaxosmithkline will deliver the inhaled antiviral drug from its location in Research Triangle Park, North Carolina to support the Defense Logistics...